{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:11:14Z","timestamp":1778044274527,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Perioper Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver dysfunction is associated with a rebalanced but fragile hemostatic system, in which alterations in coagulation factor synthesis and activity contribute to both bleeding and thrombotic risks. During liver transplantation, this fragile equilibrium is further challenged by major physiological stress. This study aimed to characterize the phase-specific intraoperative dynamics of coagulation factors V, VIII, and XIII (FV, FVIII, and FXIII) to better understand hemostatic modulation and its clinical implications during liver transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A subset of 17 liver transplant recipients receiving transfusion support without administration of recombinant FVIII or FXIII was analyzed. Measurements were obtained at three defined intraoperative time points: T1 anesthesia induction, T2 end of anhepatic phase, T3 end of surgery. Activities of FV, FVIII, and FXIII were quantified and analyzed for temporal trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All three coagulation factors declined during surgery. FV was already markedly reduced at T1 (37% (22\/55)) and further decreased to 26% at T3 ((19\/34); p\u2009=\u20090.0309). FVIII showed supranormal levels at T1 (193% (160\/254) and declined to near-normal levels at T3 (109% ((67\/143); p\u2009&lt;\u20090.0001). FXIII remained close to the lower limit of normal (T1: 68% (50\/85)); T3: (63% (55\/78)) without significant change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This prospective analysis reveals distinct, phase-specific trajectories of FV, FVIII, and FXIII during liver transplantation. Understanding these differential patterns may help identify critical periods of hemostatic vulnerability and guide individualized factor-specific therapeutic interventions to optimize perioperative coagulation management in liver transplant recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>German Clinical Trials Register (DRKS00032827).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13741-026-00695-0","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:47:33Z","timestamp":1778035653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phase-specific dynamics of coagulation factors V, VIII, and XIII during liver transplantation: insights from a prospective study"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-9822","authenticated-orcid":false,"given":"Sarah","family":"Thaler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Zorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabell","family":"Aster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionysios","family":"Koliogiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Guba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard W.","family":"Renz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8357-5552","authenticated-orcid":false,"given":"Philipp","family":"Groene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"3","key":"695_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1055\/s-0038-1646739","volume":"39","author":"L Biland","year":"1978","unstructured":"Biland L, Duckert F, Prisender S, Nyman D. Quantitative estimation of coagulation factors in liver disease. The diagnostic and prognostic value of factor XIII, factor V and plasminogen. Thromb Haemost. 1978;39(3):646\u201356 (PMID: 705694).","journal-title":"Thromb Haemost"},{"issue":"4","key":"695_CR2","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/hep.30915","volume":"71","author":"A Blasi","year":"2020","unstructured":"Blasi A, Patel VC, Adelmeijer J, Azarian S, Hernandez Tejero M, Calvo A, et al. Mixed fibrinolytic phenotypes in decompensated cirrhosis and acute-on-chronic liver failure with hypofibrinolysis in those with complications and poor survival. Hepatology. 2020;71(4):1381\u201390. https:\/\/doi.org\/10.1002\/hep.30915. (Epub 2019 Oct 24. PMID: 31465557; PMCID: PMC7187291.).","journal-title":"Hepatology"},{"issue":"2","key":"695_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2478\/jccm-2020-0011","volume":"6","author":"LN Brezeanu","year":"2020","unstructured":"Brezeanu LN, Brezeanu RC, Diculescu M, Droc G. Anaesthesia for liver transplantation: an update. J Crit Care Med. 2020;6(2):91\u2013100. https:\/\/doi.org\/10.2478\/jccm-2020-0011. (PMID: 32426515; PMCID: PMC7216023).","journal-title":"J Crit Care Med"},{"issue":"20","key":"695_CR4","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.3748\/wjg.v20.i20.6146","volume":"20","author":"B Clevenger","year":"2014","unstructured":"Clevenger B, Mallett SV. Transfusion and coagulation management in liver transplantation. World J Gastroenterol. 2014;20(20):6146\u201358. https:\/\/doi.org\/10.3748\/wjg.v20.i20.6146. (PMID: 24876736; PMCID: PMC4033453).","journal-title":"World J Gastroenterol"},{"issue":"8","key":"695_CR5","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.biocel.2003.08.002","volume":"36","author":"S Duga","year":"2004","unstructured":"Duga S, Asselta R, Tenchini ML. Coagulation factor V. Int J Biochem Cell Biol. 2004;36(8):1393\u20139. https:\/\/doi.org\/10.1016\/j.biocel.2003.08.002. (PMID: 15147718).","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"695_CR6","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1182\/blood-2015-07-607903","volume":"127","author":"K Eto","year":"2016","unstructured":"Eto K, Kunishima S. Linkage between the mechanisms of thrombocytopenia and thrombopoiesis. Blood. 2016;127(10):1234\u201341. https:\/\/doi.org\/10.1182\/blood-2015-07-607903. (Epub 2016 Jan 19. PMID: 26787737; PMCID: PMC4786834.).","journal-title":"Blood"},{"issue":"1","key":"695_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1213\/ANE.0000000000002394","volume":"126","author":"KT Forkin","year":"2018","unstructured":"Forkin KT, Colquhoun DA, Nemergut EC, Huffmyer JL. The coagulation profile of end-stage liver disease and considerations for intraoperative management. Anesth Analg. 2018;126(1):46\u201361. https:\/\/doi.org\/10.1213\/ANE.0000000000002394. (PMID: 28795966).","journal-title":"Anesth Analg"},{"issue":"5","key":"695_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/TP.0000000000002429","volume":"103","author":"A Gorgen","year":"2019","unstructured":"Gorgen A, Prediger C, Prediger JE, Chedid MF, Backes AN, de Araujo A, et al. Serum factor V is a continuous biomarker of graft dysfunction and a predictor of graft loss after liver transplantation. Transplantation. 2019;103(5):944\u201351. https:\/\/doi.org\/10.1097\/TP.0000000000002429. (PMID: 30130328).","journal-title":"Transplantation"},{"issue":"4","key":"695_CR9","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3748\/wjg.v22.i4.1541","volume":"22","author":"M Hartmann","year":"2016","unstructured":"Hartmann M, Szalai C, Saner FH. Hemostasis in liver transplantation: pathophysiology, monitoring, and treatment. World J Gastroenterol. 2016;22(4):1541\u201350. https:\/\/doi.org\/10.3748\/wjg.v22.i4.1541. (PMID: 26819521; PMCID: PMC4721987).","journal-title":"World J Gastroenterol"},{"issue":"2","key":"695_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/AIA.0000000000000139","volume":"55","author":"Z Henry","year":"2017","unstructured":"Henry Z, Northup PG. The rebalanced hemostasis system in end-stage liver disease and its impact on liver transplantation. Int Anesthesiol Clin. 2017;55(2):107\u201320. https:\/\/doi.org\/10.1097\/AIA.0000000000000139. (PMID: 28221169).","journal-title":"Int Anesthesiol Clin"},{"issue":"3","key":"695_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/s-2007-994033","volume":"19","author":"G Himmelreich","year":"1993","unstructured":"Himmelreich G, M\u00fcller C, Isenberg C, Bechstein WO, Roissant R, Riess H. Factor XIII activity during orthotopic liver transplantation. Semin Thromb Hemost. 1993;19(3):243\u20135. https:\/\/doi.org\/10.1055\/s-2007-994033. (PMID: 7689750).","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"695_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1055\/s-0037-1616143","volume":"86","author":"MJ Hollestelle","year":"2001","unstructured":"Hollestelle MJ, Thinnes T, Crain K, Stiko A, Kruijt JK, van Berkel TJ, et al. Tissue distribution of factor VIII gene expression in vivo\u2013a closer look. Thromb Haemost. 2001;86(3):855\u201361 (PMID: 11583319).","journal-title":"Thromb Haemost"},{"issue":"2","key":"695_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1160\/TH03-05-0310","volume":"91","author":"MJ Hollestelle","year":"2004","unstructured":"Hollestelle MJ, Geertzen HG, Straatsburg IH, van Gulik TM, van Mourik JA. Factor VIII expression in liver disease. Thromb Haemost. 2004;91(2):267\u201375. https:\/\/doi.org\/10.1160\/TH03-05-0310. (PMID: 14961153).","journal-title":"Thromb Haemost"},{"issue":"10","key":"695_CR14","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.dld.2019.03.011","volume":"51","author":"NM Intagliata","year":"2019","unstructured":"Intagliata NM, Davis JPE, Lafond J, Erdbruegger U, Greenberg CS, Northup PG, et al. Acute kidney injury is associated with low factor XIII in decompensated cirrhosis. Dig Liver Dis. 2019;51(10):1409\u201315. https:\/\/doi.org\/10.1016\/j.dld.2019.03.011. (PMID: 30967339).","journal-title":"Dig Liver Dis"},{"issue":"1","key":"695_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1440-1746.2006.04359.x","volume":"22","author":"M Kajihara","year":"2007","unstructured":"Kajihara M, Okazaki Y, Kato S, Ishii H, Kawakami Y, Ikeda Y, et al. Evaluation of platelet kinetics in patients with liver cirrhosis: similarity to idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol. 2007;22(1):112\u20138. https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04359.x. (PMID: 17201890).","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"695_CR16","doi-asserted-by":"publisher","first-page":"R239","DOI":"10.1186\/cc10488","volume":"15","author":"S Kozek-Langenecker","year":"2011","unstructured":"Kozek-Langenecker S, S\u00f8rensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care. 2011;15(5):R239. https:\/\/doi.org\/10.1186\/cc10488. (Epub 2011 Oct 14. PMID: 21999308; PMCID: PMC3334790).","journal-title":"Crit Care"},{"issue":"6","key":"695_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1055\/s-0040-1715102","volume":"46","author":"A Lebreton","year":"2020","unstructured":"Lebreton A, Sinegre T, Lecompte T, Talon L, Abergel A, Lisman T. Thrombin generation and cirrhosis: state of the art and perspectives. Semin Thromb Hemost. 2020;46(6):693\u2013703. https:\/\/doi.org\/10.1055\/s-0040-1715102. (Epub 2020 Aug 20. PMID: 32820480).","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"695_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/hep.1840090509","volume":"9","author":"JH Lewis","year":"1989","unstructured":"Lewis JH, Bontempo FA, Awad SA, Kang YG, Kiss JE, Ragni MV, et al. Liver transplantation: intraoperative changes in coagulation factors in 100 first transplants. Hepatology. 1989;9(5):710\u20134. https:\/\/doi.org\/10.1002\/hep.1840090509. (PMID: 2651269; PMCID: PMC3032392).","journal-title":"Hepatology"},{"issue":"1","key":"695_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1182\/hematology.2023000479","volume":"2023","author":"T Lisman","year":"2023","unstructured":"Lisman T. How to assess hemostasis in patients with severe liver disease. Hematology Am Soc Hematol Educ Program. 2023;2023(1):267\u201373. https:\/\/doi.org\/10.1182\/hematology.2023000479. (PMID: 38066858; PMCID: PMC10727047).","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"695_CR20","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","volume":"116","author":"T Lisman","year":"2010","unstructured":"Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;116(6):878\u201385. https:\/\/doi.org\/10.1182\/blood-2010-02-261891. (Epub 2010 Apr 16. PMID: 20400681).","journal-title":"Blood"},{"issue":"2","key":"695_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/s0168-8278(02)00199-x","volume":"37","author":"T Lisman","year":"2002","unstructured":"Lisman T, Leebeek FW, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37(2):280\u20137. https:\/\/doi.org\/10.1016\/s0168-8278(02)00199-x. (PMID: 12127437).","journal-title":"J Hepatol"},{"issue":"11","key":"695_CR22","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1111\/liv.13882","volume":"38","author":"T Lisman","year":"2018","unstructured":"Lisman T, Kleiss S, Patel VC, Fisher C, Adelmeijer J, Bos S, et al. In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis. Liver Int. 2018;38(11):1988\u201396. https:\/\/doi.org\/10.1111\/liv.13882. (Epub 2018 May 30. PMID: 29768734; PMCID: PMC6220788).","journal-title":"Liver Int"},{"issue":"6","key":"695_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jhep.2021.11.004","volume":"76","author":"T Lisman","year":"2022","unstructured":"Lisman T, Caldwell SH, Intagliata NM. Haemostatic alterations and management of haemostasis in patients with cirrhosis. J Hepatol. 2022;76(6):1291\u2013305. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.004. (PMID: 35589251).","journal-title":"J Hepatol"},{"issue":"3","key":"695_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MBC.0b013e328343f7be","volume":"22","author":"S Lison","year":"2011","unstructured":"Lison S, Weiss G, Spannagl M, Heindl B. Postoperative changes in procoagulant factors after major surgery. Blood Coagul Fibrinolysis. 2011;22(3):190\u20136. https:\/\/doi.org\/10.1097\/MBC.0b013e328343f7be. (PMID: 21245747).","journal-title":"Blood Coagul Fibrinolysis"},{"key":"695_CR25","unstructured":"Mangla A, Hamad H, Killeen RB, Kumar A. Factor XIII Deficiency. 2024 Feb 12. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan\u2013. PMID: 32491399."},{"issue":"3","key":"695_CR26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1152\/physrev.00016.2010","volume":"91","author":"L Muszbek","year":"2011","unstructured":"Muszbek L, Bereczky Z, Bagoly Z, Kom\u00e1romi I, Katona \u00c9. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev. 2011;91(3):931\u201372. https:\/\/doi.org\/10.1152\/physrev.00016.2010. (PMID: 21742792).","journal-title":"Physiol Rev"},{"issue":"1","key":"695_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1538-7836.2007.02772.x","volume":"6","author":"PG Northup","year":"2008","unstructured":"Northup PG, Sundaram V, Fallon MB, Reddy KR, Balogun RA, Sanyal AJ, et al. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost. 2008;6(1):2\u20139. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02772.x. (Epub 2007 Sep 24. PMID: 17892532).","journal-title":"J Thromb Haemost"},{"issue":"5","key":"695_CR28","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jhep.2010.08.018","volume":"54","author":"P Pradella","year":"2011","unstructured":"Pradella P, Bonetto S, Turchetto S, Uxa L, Comar C, Zorat F, et al. Platelet production and destruction in liver cirrhosis. J Hepatol. 2011;54(5):894\u2013900. https:\/\/doi.org\/10.1016\/j.jhep.2010.08.018. (PMID: 21145808).","journal-title":"J Hepatol"},{"issue":"1","key":"695_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jhep.2019.09.008","volume":"72","author":"AB Rassi","year":"2020","unstructured":"Rassi AB, d\u2019Amico EA, Tripodi A, da Rocha TRF, Migita BY, Ferreira CM, et al. Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: effect on conventional coagulation tests and thrombomodulin-modified thrombin generation. J Hepatol. 2020;72(1):85\u201394. https:\/\/doi.org\/10.1016\/j.jhep.2019.09.008. (Epub 2019 Sep 16. PMID: 31536747).","journal-title":"J Hepatol"},{"issue":"10","key":"695_CR30","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1016\/j.transproceed.2020.05.006","volume":"52","author":"TK Rengein\u00e9","year":"2020","unstructured":"Rengein\u00e9 TK, M\u00e1th\u00e9 Z, Piros L, Dinya E, Smudla A, M\u00e1ndli T, et al. How much is the inevitable loss of different coagulation factors during blood product-free liver transplantations? Transplant Proc. 2020;52(10):2988\u201395. https:\/\/doi.org\/10.1016\/j.transproceed.2020.05.006. (Epub 2020 Jul 9. PMID: 32653159).","journal-title":"Transplant Proc"},{"issue":"10","key":"695_CR31","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/s1357-2725(97)00040-x","volume":"29","author":"J Rosing","year":"1997","unstructured":"Rosing J, Tans G. Factor V. Int J Biochem Cell Biol. 1997;29(10):1123\u20136. https:\/\/doi.org\/10.1016\/s1357-2725(97)00040-x. (PMID: 9438374).","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"695_CR32","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/jth.14011","volume":"16","author":"T Sinegre","year":"2018","unstructured":"Sinegre T, Duron C, Lecompte T, Pereira B, Massoulier S, Lamblin G, et al. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis. J Thromb Haemost. 2018;16(6):1132\u201340. https:\/\/doi.org\/10.1111\/jth.14011. (Epub 2018 May 17. PMID: 29577605).","journal-title":"J Thromb Haemost"},{"issue":"2","key":"695_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1478-3231.2005.01205.x","volume":"26","author":"F Tacke","year":"2006","unstructured":"Tacke F, Fiedler K, von Depka M, Luedde T, Hecker H, Manns MP, et al. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease. Liver Int. 2006;26(2):173\u201381. https:\/\/doi.org\/10.1111\/j.1478-3231.2005.01205.x. (PMID: 16448455).","journal-title":"Liver Int"},{"issue":"1","key":"695_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bpa.2020.03.002","volume":"34","author":"C Thai","year":"2020","unstructured":"Thai C, Oben C, Wagener G. Coagulation, hemostasis, and transfusion during liver transplantation. Best Pract Res Clin Anaesthesiol. 2020;34(1):79\u201387. https:\/\/doi.org\/10.1016\/j.bpa.2020.03.002. (Epub 2020 Mar 16. PMID: 32334789).","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"5","key":"695_CR35","doi-asserted-by":"publisher","first-page":"e70179","DOI":"10.1111\/ctr.70179","volume":"39","author":"S Thaler","year":"2025","unstructured":"Thaler S, Zorn A, Aster I, Koliogiannis D, Renz BW, Guba M, et al. Hyperfibrinolysis detection during liver transplantation using viscoelastometry. Clin Transplant. 2025;39(5):e70179. https:\/\/doi.org\/10.1111\/ctr.70179. (PMID: 40349145; PMCID: PMC12066000).","journal-title":"Clin Transplant"},{"issue":"2","key":"695_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJMra1011170","volume":"365","author":"A Tripodi","year":"2011","unstructured":"Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147\u201356. https:\/\/doi.org\/10.1056\/NEJMra1011170. (PMID: 21751907).","journal-title":"N Engl J Med"},{"issue":"3","key":"695_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/hep.20569","volume":"41","author":"A Tripodi","year":"2005","unstructured":"Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41(3):553\u20138. https:\/\/doi.org\/10.1002\/hep.20569. (PMID: 15726661).","journal-title":"Hepatology"},{"issue":"1","key":"695_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11739-009-0302-z","volume":"5","author":"A Tripodi","year":"2010","unstructured":"Tripodi A, Primignani M, Mannucci PM. Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged. Intern Emerg Med. 2010;5(1):7\u201312. https:\/\/doi.org\/10.1007\/s11739-009-0302-z. (Epub 2009 Aug 28. PMID: 19714443).","journal-title":"Intern Emerg Med"},{"issue":"1","key":"695_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12876-024-03399-1","volume":"24","author":"Z Wu","year":"2024","unstructured":"Wu Z, Xiao Y, Qi Z, Guo T, Tong H, Wang Y. Effect of factor VIII and FVIII\/PC ratio on portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis. BMC Gastroenterol. 2024;24(1):320. https:\/\/doi.org\/10.1186\/s12876-024-03399-1. (PMID: 39300356; PMCID: PMC11411769).","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"695_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00423-015-1290-2","volume":"400","author":"MC Zulian","year":"2015","unstructured":"Zulian MC, Chedid MF, Chedid AD, Grezzana Filho TJ, Leipnitz I, de Araujo A, et al. Low serum factor V level: early predictor of allograft failure and death following liver transplantation. Langenbecks Arch Surg. 2015;400(5):589\u201397. https:\/\/doi.org\/10.1007\/s00423-015-1290-2. (PMID: 25708642).","journal-title":"Langenbecks Arch Surg"}],"container-title":["Perioperative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13741-026-00695-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13741-026-00695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13741-026-00695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:17:41Z","timestamp":1778041061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13741-026-00695-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["695"],"URL":"https:\/\/doi.org\/10.1186\/s13741-026-00695-0","relation":{},"ISSN":["2047-0525"],"issn-type":[{"value":"2047-0525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of Ludwig-Maximilians-University (LMU), Munich, Germany (No 23\u20140613; 2023, Aug 30). Written informed consent was obtained from all patients before study inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"P.G. received lecture honoraria from CSL Behring and Werfen; all other authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}